C4 Therapeutics Inc (NAS:CCCC) Stock News, Headlines & Updates
C4 Therapeutics Inc Stock News from GuruFocus
- 1
Aug 12, 2026
Is C4 Therapeutics Inc (CCCC) Overvalued After Q2 Earnings Reveal $6.6M Revenue? GF Score: 51/100
• 7:00pm
Aug 11, 2026
CCCC Looks 81.0% Overvalued on GF Valueâ„¢
• 6:45am
8-K - C4 Therapeutics, Inc. (0001662579)
• 7:00pm
10-Q - C4 Therapeutics, Inc. (0001662579)
• 7:00pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news